| # | Drug | Count |
|---|---|---|
| 0 | CLONAZEPAM | 18 |
| 1 | ASPIRIN | 16 |
| 2 | OLANZAPINE | 16 |
| 3 | ASPIRIN 325 MG | 15 |
| 4 | ASPIRIN 81 MG | 15 |
| 5 | HALOPERIDOL | 15 |
| 6 | HALOPERIDOL LACTATE | 15 |
| 7 | TESTOSTERONE | 15 |
| 8 | PROMETHAZINE HYDROCHLORIDE | 14 |
| 9 | ALBUTEROL SULFATE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | APRACLONIDINE | 1 | 0.0090 |
| 1 | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | 1 | 0.0030 |
| 2 | MEPIVACAINE HYDROCHLORIDE | 3 | 0.0026 |
| 3 | HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX | 2 | 0.0020 |
| 4 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 5 | NIMODIPINE | 1 | 0.0009 |
| 6 | PROMETHAZINE HYDROCHLORIDE | 14 | 0.0007 |
| 7 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 3 | 0.0007 |
| 8 | VERAPAMIL HYDROCHLORIDE | 3 | 0.0007 |
| 9 | FLURBIPROFEN | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 41 |
| 1 | Corticosteroid [EPC] | 34 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 3 | Atypical Antipsychotic [EPC] | 27 |
| 4 | Opioid Agonist [EPC] | 19 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 16 |
| 6 | Androgen [EPC] | 15 |
| 7 | Typical Antipsychotic [EPC] | 15 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 14 |
| 9 | beta-Adrenergic Blocker [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 1 | Typical Antipsychotic [EPC] | 15 | 0.0006 |
| 2 | Androgen [EPC] | 15 | 0.0005 |
| 3 | Calcitonin [EPC] | 1 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 5 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 8 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 9 | Sympathomimetic-like Agent [EPC] | 4 | 0.0001 |